Clinical Trial Update: Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the safety and efficacy of lyophilized faecal microbiota transplantation delivered as capsules for Irritable Bowel Syndrome;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Lyophilized Faecal Microbiota Transplantation Capsules (fecal microbiota transplantation capsules)

Snippet

Sponsor: University of Rijeka | Conditions: Irritable Bowel Syndrome (IBS) | Phase 1, Phase 2 | Status: RECRUITING